http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021156391-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ad2eb45a861c9878529fea009a5140b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-80
filingDate 2021-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1a98bbf84643d0c5980142d12edabdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb539f87a786759954b62752b2b34cf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f518d0b696961d2ec2e5b86e4fa57d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaa5cd2c5e13b6ab1925dc014aa469ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d7f12d5e4fae29453633bd4474ac0dc
publicationDate 2021-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021156391-A1
titleOfInvention Method for capturing and identifying cellular agglutinates for detecting multiplex anti-erythrocyte antibodies
abstract The present invention relates to an in-vitro method for detecting anti-erythrocyte antibodies in a sample, comprising at least the following steps: a) bringing the sample into contact with one or more test erythrocytes or a suspension of one or more test erythrocytes having a known phenotype, under conditions likely to induce hemagglutination, so as to obtain a reaction mixture; b) bringing the reaction mixture into contact with a solid substrate containing a plurality of defined adsorption areas which have previously fixed antibodies or antibody fragments capable of binding antigenic determinants present on the one or more test erythrocytes; c) ascertaining the presence or absence of a hemagglutination reaction in at least one of the adsorption areas so as to detect the presence or absence of anti-erythrocyte antibodies in the sample; the steps a) and b) being carried out separately or simultaneously.
priorityDate 2020-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006100477-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019158726-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007077605-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008148886-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009007649-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0223978-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012052874-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007051844-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8501354-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012010666-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226471500

Total number of triples: 29.